Stability study of a clonidine oral solution in a novel vehicle designed for pediatric patients

References

• Agence Nationale de Sécurité du Médicament (ANSM). 2007. Bonnes pratiques de préparation [Good preparation practices]. http://ansm.sante.fr (Accessed 2017 Mar 15).
   Google Scholar
• Bada HS, Sithisarn T, Gibson J, Garlitz K, Caldwell R, Capilouto G, Li Y, Leggas M, Breheny P. 2015. Morphine versus clonidine for neonatal abstinence syndrome. Pediatrics. 135:383–391.
   PubMed Web of Science ®Google Scholar
• Baertschi SW, Jansen JP, Alsante KM. 2011. Pharmaceutical stress testing: predicting drug degradation. 2nd ed. Boca Raton: CRC Press. Chapter 2, Stress testing: a predictive tool; p.10–48.
   Google Scholar
• Bagley SM, Wachman EM, Holland E, Brogly SB. 2014. Review of the assessment and management of neonatal abstinence syndrome. Addict Sci Clin Pract. 9:19.
   PubMedGoogle Scholar
• Batchelor H, Salunke S, Tuleu C. 2015. Formulating better medicines for children-reflections. Int J Pharm. 492:301–303.
   PubMed Web of Science ®Google Scholar
• Bellis JR, Kirkham JJ, Thiesen S, Conroy E. 2013. Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital. BMC Med. 11:238.
   PubMed Web of Science ®Google Scholar
• Brayfield A. 2014. The 38th edition of Martindale: the complete drug reference. London: Pharmaceutical Press.
   Google Scholar
• Clonidine hydrochloride. 2010. In: Jackson M, Lowey A, editors. Handbook of extemporaneous preparation. A Guide to Pharmaceutical Compounding. London: Pharmaceutical Press; p. 144–149.
   Google Scholar
• Clonidine hydrochloride, 2008. Monograph 01/2008:0477. European Pharmacopoeia, 9th ed. Conseil de l’Europe. F-Strasbourg.
   Google Scholar
• Davies H, Gilbert R, Johnson K, Petersen I, Nazareth I, O’Donnell M, Guttmann A, Gonzalez-Izquierdo A. 2016. Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia and Ontario, Canada. Arch Dis Child Fetal Neonatal Ed. 101:26–30.
   Web of Science ®Google Scholar
• de Goede AL, Boedhram RR, Eckhardt M, Hanf LM, Koch BCP, Vermaat CH, Vermes A. 2012. Development and validation of a paediatric oral formulation of clonidine hydrochloride. Int J Pharm. 433:119–120.
   PubMed Web of Science ®Google Scholar
• EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources added to Food). 2015. Scientific opinion on the re-evaluation of sorbic acid (E 200), potassium sorbate (E 202) and calcium sorbate (E 203) as food additives. EFSA J. 13:4144.
   Google Scholar
• Ensom MHH, Decarie D. 2014. Stability of extemporaneously compounded clonidine in glass and plastic bottles and plastic syringes. Can J Hosp Pharm. 67:308–310.
   PubMedGoogle Scholar
• Erickson SJ, Duncan A. 1998. Clonidine poisoning. An emerging problem: epidemiology, clinical features, management and preventive strategies. J Paediatr Child Health. 34:280–282.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency (EMA). 2012. Guideline on pharmaceutical development of medicines for paediatric use. EMA/CHMP/QWP/805880/2012 Rev.2. www.ema.europa.eu (Accessed 2017 Mar 30).
   Google Scholar
• European Medicines Evaluation Agency (EMEA). 2001. Note for guidance on in-use stability testing of human medicinal products. CPMP/QWP/2934/99.2001. www.ema.europa.eu (Accessed 2017 Apr 15).
   Google Scholar
• European Paediatric formulation initiative (EUPFI). http://www.eupfi.org.
   Google Scholar
• European Pharmacopoeia, 2017. Physical and physicochemical methods (2.2.), Microbiological examination of non-sterile products: test for specified micro-organisms (2.6.13.) and Microbiological quality of non-sterile pharmaceutical preparations and substances for pharmaceutical use (5.1.4.). 9th ed. F-Strasbourg: Conseil de l’Europe.
   Google Scholar
• Fernández PA, Cabañas PM, Clemente BS, Oliveras AM, Castillo SF, Hidalgo AE. 2007. Osmolality of oral liquid dosage forms to be administered to newborns in a hospital. Farm Hosp. 3:311–314.
   Google Scholar
• Guilli T, Tall ML, Raymond F, Rome P, Diouf E, Gerard P, Perraud M, Pivot C, Pirot F. 2012. Validation de l’activité antimicrobienne du sorbate de potassium dans un excipient liquide. SNPHPU 2012: Syndicat National des Pharmaciens Praticiens Hospitaliers et Praticiens Hospitaliers Universitaires; Sept 19–21; AJACCIO (FR).
   Google Scholar
• Helin-Tanninen M, Autio K, Keski-Rahkonen P, Naaranlahti T, Järvinen K. 2012. Comparison of six different suspension vehicles in compounding of oral extemporaneous nifedipine suspension for paediatric patients. Eur J Hosp Pharm. 19:432–437.
   Google Scholar
• International Council for Harmonisation. ICH Q2 (R1). Validation of analytical procedures: text and methodology. www.ich.org (Accessed 2016 Mar 30).
   Google Scholar
• Ivanovska V, Rademaker CMA, van Dijk L, Mantel-Teeuwisse AK. 2014. Pediatric drug formulations: a review of challenges and progress. Pediatrics. 134:2013–2032.
   Web of Science ®Google Scholar
• Kappagoda C, Schell DN, Hanon RM, Hutchins P. 1998. Clonidine overdose in childhood: implications of increased prescribing. J Paediatr Child Health. 34:508–512.
   PubMed Web of Science ®Google Scholar
• Kostecka D, Duncan MR, Wagenknecht D. 1998. Formulation of a stable parenteral product; clonidine hydrochloride injection. J Pharm Sci Technol. 52:320–325.
   Google Scholar
• Levinson M, Johnson C. 1992. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid. Am J Hosp Pharm. 49:122–125.
   PubMedGoogle Scholar
• Ma C, Decarie D, Ensom MHH. 2014. Stability of clonidine suspension in oral plastic syringes. Am J Health Syst Pharm. 71:657–661.
   PubMed Web of Science ®Google Scholar
• Mason J, Pirmohamed M, Nunn T. 2012. Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature. Eur J Clin Pharmacol. 68:21–28.
   PubMed Web of Science ®Google Scholar
• Michael Davidson P, Sofos JN, Branen AL. 2005. Antimicrobials in food. 3rd ed. Boca Raton (FL): Taylor & Francis; p. 11–90.
   Google Scholar
• Nellis G, Metsvaht T, Varendi H, Toompere K, Lass J, Mesek I, Nunn AJ, Turner MA, Lutsar I, ESNEE consortium. 2015. Potentially harmful excipients in neonatal medicines: a pan-European observational study. Arch Dis Child. 100:694–699.
   PubMed Web of Science ®Google Scholar
• Pediatric Formulations Platform. BPCA, National Institutes of Health. Inter-agency agreement between the Eunice Kennedy Shriver National Institute of Children Health and Human Development (ICHD) and the US Food and Drug Administration (FDA). https://bpca.nichd.nih.gov/Pages/Index.aspx (Accessed 2016 Dec 15).
   Google Scholar
• Romano MJ, Dinh A. 2001. A 1000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder. Pediatrics. 108:471–472.
   PubMed Web of Science ®Google Scholar
• Rood JM, Engels MJ, Ciarkowski SL, Wagenknecht LD, Dickinson CJ, Stevenson JG. 2014. Variability in compounding of oral liquids for pediatric patients: a patient safety concern. J Am Pharm Assoc. 54:383–389.
   Google Scholar
• Rowe RC, Sheskey PJ, Cook WG, Fenton ME. 2012. Handbook of pharmaceutical excipients [electronic database]. 7th ed. London: Pharmaceutical Press and American Pharmacists Association.
   Google Scholar
• Sauberan JB, Phuong P, Ilog ND, Rossi SS. 2016. Stability and osmolality of extemporaneously prepared clonidine oral liquid for neonates. Ann Pharmacother. 50:243–244.
   PubMed Web of Science ®Google Scholar
• Schlatter J, Bourguignon E, Majoul E, Kabiche S, Issa-bella B, Cisternino S, Fontan J-E. 2016. Stability study of oral paediatric idebenone suspensions. Pharm Dev and Tech. 22:296–299.
   PubMed Web of Science ®Google Scholar
• Siu A, Robinson CA. 2014. Neonatal abstinence syndrome: essentials for the practitioner. J Pediatr Pharmacol Ther. 19:147–155.
   PubMedGoogle Scholar
• Standing JF, Tuleu C. 2005. Paediatric formulations-getting to the heart of the problem. Int J Pharm. 300:56–66.
   PubMed Web of Science ®Google Scholar
• Streetz VN, Gildon BL, Thompson DF. 2016. Role of clonidine in neonatal abstinence syndrome: a systematic review. Ann Pharmacother. 50:301–310.
   PubMed Web of Science ®Google Scholar
• Suchard J, Graeme K. 2002. Pediatric clonidine poisoning as a result of pharmacy compounding error. Pediatr Emerg Care. 18:295–296.
   PubMed Web of Science ®Google Scholar
• Tolia V, Patrick V, Bennett M, Murthy K, Sousa J, Smith P, Clark R, Spitzer A. 2015. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med. 372:2118–2126.
   PubMed Web of Science ®Google Scholar
• Wachman EM, Schiff DM. 2016. Bringing attention to a need for a standardized treatment and weaning protocol for neonatal abstinence syndrome. Transl Pediatr. 5:12–15.
   PubMed Web of Science ®Google Scholar